Corinne E. Atton

+1 347-773-3883 (Direct)

corinne.atton@draperllc.com

Corinne E. Atton has extensive experience advising clients in complex, high-stakes commercial and patent litigations, and arbitrations.  She has advised on a wide variety of technologies, with a particular focus on climate change mitigation technologies, biotechnology, biologics and pharmaceuticals.  

Corinne also has experience advising on and litigating high-stakes U.S. domestic and international interstate and transboundary water disputes.   

Corinne is an accomplished litigator and trial attorney.  She has represented clients before the U.S. Supreme Court, the Federal Circuit, and various U.S. district courts.  She has also represented clients in inter partes review (IPR) and post-grant review (PGR) proceedings before the U.S. Patent Trial and Appeal Board (the administrative law body of the U.S. Patent and Trademark Office). 

Corinne formerly practiced as a barrister in England and Wales where she represented clients in high-stakes patent, trademark, commercial litigation, and international arbitration matters.  While working in the U.K., she represented clients before the Court of Appeal (England and Wales), the Chancery Division (Patents Court) of the High Court of Justice of England and Wales, and the Intellectual Property Enterprise Court.  

Before joining Draper & Draper, Corinne was a litigator for more than a decade at WilmerHale in London and New York, and at Weil, Gotshal and Manges, and Fitzpatrick, Cella, Harper and Scinto (now Venable LLP) in New York. 

Corinne has a Bachelor of Science honors degree in Human Genetics from University College London (UCL), and a Master of Laws degree from Columbia Law School (Harlan Fiske Stone Scholar). 

Corinne is admitted to the bar in New York, and in England and Wales; and has rights of audience before the U.S. Supreme Court, the Federal Circuit, the U.S. Court of Appeals for the Second Circuit, S.D.N.Y, E.D.N.Y, the District of New Mexico, and all courts in England and Wales, including the U.K. Supreme Court.    

​

SELECT REPRESENTATIONS

​

International Arbitration:​​

• Counsel for Professor George A. Bermann (Gellhorn Professor of Law and Monnet Professor in European Union Law, Columbia Law School), Amicus Curiae Brief in Support of Petition For Writ of Certiorari, Beijing Shougang Mining Investment Company, Ltd., et al., v. Mongolia, 21-1244 (U.S. Supreme Court)

• Represented a leading international luxury brand in an IP and franchise dispute with a Middle Eastern franchisee in an ICDR administered arbitration

• Represented a Central Asian state-owned electric utility in a dispute concerning a hydroelectric plant in an ICC arbitration seated in Dubai 

​

Natural Resources - Transboundary Water Disputes:

• Texas v. New Mexico & Colorado, No. 141 Orig., U.S. Supreme Court

• International Law Committee of the New York City Bar Association, Amicus Curiae Brief in Suppo rt of Neither Party, State of Mississippi v. State of Tennessee et al., No. 143 Orig., U.S. Supreme Court (2021)

​

Other Supreme Court Litigation:

• Counsel for Professors Joost Blom, K.C. and Dr. Aubin Calvert, Amicus Curiae Brief​ in Support of Petition For Writ of Certiorari, Falkbuilt Ltd., et al., v. DIRTT Environmental Solutions, Inc., et al., 23-131 (U.S. Supreme Court)

• Counsel of Record, Biotechnology Innovation Organization (BIO), Amicus Curiae Brief in the Support of Petition For Writ Of Certiorari, Athena Diagnostics, Inc. v. Mayo Collaborative Svcs., LLC, No. 19-430, U.S. Supreme Court* 

​

Patent & IP Litigation:

• Certain Child Carriers, Components Thereof and Products Containing the Same, Inv. No. 337-TA-1154, 337-TA-1154 (U.S. International Trade Commission)*

• Astellas Pharma Inc. v. Actavis Elizabeth LLC et al., 1:16-cv-905 (D. Del.)*

• Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical et al., 1:14-cv-1043 (D. Del.)*

• Biogen MA, Inc. v. Japanese Foundation For Cancer Research, 14-1695 (Fed. Cir.)*

• Amdocs (Israel) Limited v. Openet Telecom, Inc., et al., 1:10-cv-00910 (E. D. Va.); 13-1212 (Fed. Cir. 2014)*

• Jay, M.D. v. Spectrum Brands Holdings, Inc. et al., 1:13-cv-08137 (S.D.N.Y.)*

• Sciele Pharma Inc., et al. v. Lupin Ltd., et. al., 1:09-cv-00037 (D. Del.); 12-1228 (Fed. Cir. 2012)*

• Novartis Pharmaceuticals Corp. v. Actavis Inc. et al., 1:12-cv-366 (D. Del.)*

• GlaxoSmithKline LLC v. Anchen Pharmaceuticals Inc. et al., 1:11-cv-46 (D. Del.)*

• Tyco Healthcare Group LP v. CR Bard Inc. et al., 1:09-cv-00264 (D. Del.)*

• Fenner Investments, Ltd. v. Dell, Inc. and Hewlett-Packard Co., 6:08-cv-273 (E.D. Tex.)*

• Unilin Beheer B.V. v. Berry Floor N.V. [2005] EWCA Civ 1292 (U.K. Court of Appeal)*

• Koninklijke Philips Electronics N.V. v. Remington Consumer Prod. Ltd. [2006] EWCA Civ 16 (U.K. Court of Appeal)*

​

USPTO PTAB Proceedings:

• IPR2020-00165 (Bausch Health Companies Inc. v. Flow Pharma Inc.)*

• IPR2018-00079 (Sawai USA, Inc. v. Astellas Pharma Inc.)*

• IPR2016-00078 (Par Pharmaceutical, Inc. v Novartis AG)*

​​

       *Experience prior to joining Draper & Draper LLC

​